What is Neumora Therapeutics, Inc. (NMRA) stock price today?

Neumora Therapeutics, Inc. (NMRA) currently trades at $2.25 per share. The stock has a market capitalization of $405.57M and a P/E ratio of —x.

Is NMRA stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Neumora Therapeutics, Inc. has a Smart Value Score of 24/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

NMRA

Neumora Therapeutics, Inc.

NASDAQ: NMRA · HEALTHCARE · BIOTECHNOLOGY

$2.25

+0.00% today

Updated 2026-04-29

Market cap

$405.57M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-1.45

Dividend yield

—

52W range

$1 – $4

Volume

1.1M

Market cap

$405.57M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-1.45

Dividend yield

—

52W range

$1 – $4

Volume

1.1M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

5.0

Quality

C+

3.0

Profitability

5.0

Valuation

C+

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →204 stocks currently score above 75

Price targets

Analyst target

$8.91

+296.00%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

2 Strong Buy5 Buy1 Hold0 Sell1 Strong Sell

Price chart

X-Ray snapshot

Strengths

Insufficient data

Risks

- Thin margins at 0.00%

- Negative free cash flow $-47.97M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	$0.00
Net income	$-130.90M	$-235.93M	$-243.79M	$-236.93M	$-59.45M
EPS	—	—	—	—	$-1.45
Free cash flow	$-115.41M	$-163.40M	$-182.94M	$-206.44M	$-47.97M
Profit margin	—	—	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
NMRA	$405.57M	24	4.3	3.0	5.0	5.0	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$336.47B	54	5.3	5.5	7.3	4.8	+42.09%	Buy
AZN	$287.11B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Neumora Therapeutics, Inc. trades at $2.25. Our Smart Value Score of 24/100 indicates the stock is weak.

Frequently asked questions

What is Neumora Therapeutics, Inc.'s stock price?

Neumora Therapeutics, Inc. (NMRA) trades at $2.25.

Is Neumora Therapeutics, Inc. overvalued?

Smart Value Score 24/100 (Grade F, Strong Sell).

What is the price target of Neumora Therapeutics, Inc. (NMRA)?

The analyst target price is $8.91, representing +296.0% upside from the current price of $2.25.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio—

ROE-121.20%

Beta3.12

50D MA$2.68

200D MA$2.17

Shares out0.18B

Float0.10B

Short ratio—

Avg volume1.1M

Performance

1 week-2.60%

1 month+16.58%

3 months+10.29%

YTD+25.70%

1 year—

3 years—

5 years—

Compare

NMRA vs LLY →NMRA vs JNJ →NMRA vs ABBV →Stock screener →